Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
Harvard Bioscience (Nasdaq: HBIO) has scheduled its second quarter 2025 earnings conference call for August 11, 2025, at 8:00 AM ET. The company will release its financial results for the quarter ended June 30, 2025, before the market opens on the same day.
Interested participants who wish to ask questions during the call must pre-register to receive dial-in numbers and a unique PIN. An audio-only webcast option is also available through the company's investor website. The earnings release and related presentation materials will be accessible through Harvard Bioscience's Investor Relations section.
Harvard Bioscience (Nasdaq: HBIO) ha programmato la conference call per la presentazione dei risultati del secondo trimestre 2025 per il 11 agosto 2025, alle 8:00 AM ET. La società pubblicherà i risultati finanziari relativi al trimestre chiuso il 30 giugno 2025 prima dell'apertura del mercato nello stesso giorno.
I partecipanti interessati che desiderano porre domande durante la call devono registrarsi in anticipo per ricevere i numeri di accesso e un PIN univoco. È disponibile anche un'opzione webcast solo audio tramite il sito web per gli investitori della società. Il comunicato sui risultati e i materiali di presentazione correlati saranno accessibili nella sezione Investor Relations di Harvard Bioscience.
Harvard Bioscience (Nasdaq: HBIO) ha programado su conferencia telefónica para el reporte de resultados del segundo trimestre de 2025 para el 11 de agosto de 2025 a las 8:00 AM ET. La compañía publicará sus resultados financieros correspondientes al trimestre finalizado el 30 de junio de 2025 antes de la apertura del mercado ese mismo día.
Los participantes interesados que deseen hacer preguntas durante la llamada deben preinscribirse para recibir los números de acceso y un PIN único. También está disponible una opción de webcast solo de audio a través del sitio web para inversores de la compañía. El comunicado de resultados y los materiales de presentación relacionados estarán accesibles en la sección de Relaciones con Inversores de Harvard Bioscience.
Harvard Bioscience (나스닥: HBIO)는 2025년 2분기 실적 컨퍼런스 콜을 2025년 8월 11일 오전 8시(동부시간)에 예정하고 있습니다. 회사는 2025년 6월 30일 종료된 분기 실적을 같은 날 시장 개장 전에 발표할 예정입니다.
콜 중 질문을 원하는 참가자는 사전 등록을 통해 접속 번호와 고유 PIN을 받아야 합니다. 회사 투자자 웹사이트를 통해 오디오 전용 웹캐스트 옵션도 제공됩니다. 실적 발표 자료와 관련 프레젠테이션 자료는 Harvard Bioscience 투자자 관계 섹션에서 확인할 수 있습니다.
Harvard Bioscience (Nasdaq : HBIO) a programmé sa conférence téléphonique pour les résultats du deuxième trimestre 2025 le 11 août 2025 à 8h00 ET. La société publiera ses résultats financiers pour le trimestre clos au 30 juin 2025 avant l'ouverture des marchés ce même jour.
Les participants souhaitant poser des questions lors de l’appel doivent s’inscrire à l’avance pour recevoir les numéros d’accès et un code PIN unique. Une option de webdiffusion audio uniquement est également disponible via le site web des investisseurs de la société. Le communiqué de résultats et les documents de présentation associés seront accessibles dans la section Relations Investisseurs de Harvard Bioscience.
Harvard Bioscience (Nasdaq: HBIO) hat seine Telefonkonferenz zur Bekanntgabe der Ergebnisse für das zweite Quartal 2025 für den 11. August 2025 um 8:00 Uhr ET angesetzt. Das Unternehmen wird die Finanzergebnisse für das am 30. Juni 2025 endende Quartal noch vor Markteröffnung am selben Tag veröffentlichen.
Interessierte Teilnehmer, die während der Konferenz Fragen stellen möchten, müssen sich im Voraus registrieren, um Einwahlnummern und eine eindeutige PIN zu erhalten. Eine reine Audio-Webcast-Option ist ebenfalls über die Investor-Website des Unternehmens verfügbar. Die Gewinnmitteilung und die dazugehörigen Präsentationsunterlagen sind im Bereich Investor Relations von Harvard Bioscience zugänglich.
- None.
- None.
HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 11, 2025, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.
Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.
Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.
About Harvard Bioscience
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.
Investor Inquiries:
(508) 893-3120
investors@harvardbioscience.com
FAQ
When is Harvard Bioscience (HBIO) releasing Q2 2025 earnings?
How can investors join the Harvard Bioscience Q2 2025 earnings call?
Where can I find Harvard Bioscience's Q2 2025 earnings materials?
What period will Harvard Bioscience's Q2 2025 earnings cover?
